benzyl 2,4-dioxo-1,3,7-triazaspiro[4.4]nonane-7-carboxylate, 95%, 100mg

5-((7-Chloro-1H-indol-3-yl)methyl)-3-methylimidazolidine-2,4-dione, 98.0%, 25mg

2-Phenylpyrimidine-4-carboxylic acid, 95.0%, 2.5g

2-(3-Bromoquinolin-6-yl)acetic acid, 95.0%, 1g

3-Chloro-5-iodobenzonitrile, 99.0%, 25g

tert-Butyl (5-acetyl-6-fluoropyridin-2-yl)carbamate, 97%, 1g

5-(4-Bromo-2-methylphenyl)-1,3-oxazole, 98%, 500mg

GC capillary column ROTI®Cap-35 MS, 30 m, 0.32 mm, 1 Piece(s)

2,2-Diethoxy-N-methylethan-1-amine, 95%, 25g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-fluoro-1H-indol-3-yl)propanoic acid, 97%, 250mg

N,N,N',N'-Tetramethyl-1,2-diaminopropane>92.0%(GC)25mL

5-(Hydroxyimino)pyrimidine-2,4,6(1H,3H,5H)-trione hydrate, 95.0%, 5g

4-Chloro-3-ethylbenzoic acid, 99.0%, 250mg